# A Novel 68Ga Labeled FAP Ligand PET/CT in Patients With Various Malignant Tumors

> **NCT06186427** · NA · UNKNOWN · sponsor: **Guangdong Provincial People's Hospital** · enrollment: 30 (estimated)

## Conditions studied

- Cancer
- Malignant Neoplasm
- Tumors
- Metastatic Cancer

## Interventions

- **DIAGNOSTIC_TEST:** 68Ga-DOTA-GPFAPI-04 PET/CT

## Key facts

- **NCT ID:** NCT06186427
- **Lead sponsor:** Guangdong Provincial People's Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2024-01-13
- **Primary completion:** 2025-08-31
- **Final completion:** 2025-12-31
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2024-01-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06186427

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06186427, "A Novel 68Ga Labeled FAP Ligand PET/CT in Patients With Various Malignant Tumors". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06186427. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*